Skip to content

A prospective, multicenter, cohort study on the treatment of ischemic stroke with stable coronary heart disease by Huoitong Granule based on the theory of "heart-brain combined treatment and Huoitong"

A prospective, multicenter, cohort study on the treatment of ischemic stroke with stable coronary heart disease by Huoitong Granule based on the theory of "heart-brain combined treatment and Huoitong"

Status
Active, not recruiting
Phases
Phase 4
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300076657
Enrollment
Unknown
Registered
2023-10-13
Start date
2023-11-16
Completion date
Unknown
Last updated
2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atherosclerotic ischemic stroke with stable coronary heart disease

Interventions

Treatment cohort (On the basis of conventional Western medicine treatment, the use of Huoitong granule treatment, in principle, does not use other similar Chinese medicine ):None
Control cohort (Conventional western medicine treatment, in principle do not use other similar Chinese medicine.):None

Sponsors

Guangdong Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Clinically diagnosed atherosclerotic ischemic stroke with stable coronary heart disease; 2. Age =18 years old; 3. The mRS Score of this ischemic stroke was >2, and the course of the disease was within 14 days; 4. The mRS Score before the onset of non-first ischemic stroke was 0~1; 5.5 points =NIHSS score =20 points; 6.CCS is graded from Class II to Class IV; which may affect nerve function examination;7.The informed consent process is compliant.

Exclusion criteria

Exclusion criteria: Excluding patients with limb movement dysfunction caused by claudication, osteoarthritis, rheumatoid arthritis, gouty arthritis, etc., which may affect nerve function examination;

Design outcomes

Primary

MeasureTime frame
MACE;mRS;NIHSS;SAQ;

Countries

China

Contacts

Public ContactCAI Yefeng

Guangdong Hospital of Traditional Chinese Medicine

caiyefeng@126.com+86 136 3133 3842

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026